Veera Padmanabhan

Veera Padmanabhan has extensive experience in the biopharmaceutical industry, holding advanced leadership roles such as Executive Director at AstraZeneca, where responsibilities included providing technical direction for biologics drug substance manufacturing and overseeing new product introductions and process improvements from August 2015 to January 2022. Previously, Veera served as Senior Director and Global Bioanalytics Network Lead, managing a team focused on analytical technology and project management. Additional experience includes serving as Director of R&D at MedImmune, where efforts emphasized analytical biotechnology development and quality by design, and as Director of Operational Excellence and Biotech Pipeline Lead at Monsanto. Veera's career began at Pioneer Hi-Bred International Inc, contributing expertise in process optimization and Six Sigma methodologies. Academic credentials include a PhD from Texas A&M University and an MBA from Iowa State University's Ivy College of Business.